New Delhi, Sep 3 (PTI) Drug firm Strides Pharma Science on Thursday said it has received approval from the US health regulator for generic Prednisone tablets used as an anti-inflammatory medication.

Strides Pharma Global Pte Ltd, Singapore, company's step-down wholly owned subsidiary, has received approval for Prednisone tablets USP in the strength of 1 mg from the United States Food & Drug Administration (USFDA), Strides Pharma Science said in a filing to the BSE.

Also Read | Coronavirus is Not the Deadliest Disease That Can Befall Mankind, Says Singapore PM Lee Hsien Loong.

The product is a generic version of Schering Corporation's Meticorten tablets in the same strength, it added.

The product will be manufactured at the company's facility at Bengaluru and will be marketed by Strides Pharma Inc in the US market, the filing said.

Also Read | OnePlus Nord Next Online Sale on September 7, 2020, via Amazon India.

According to IQVIA MAT July 2020 data, the US market for Prednisone tablets USP 1 mg is approximately USD 12 million (about Rs 88 crore), it added.

Prednisone belongs to a class of drugs known as corticosteroids and is used as an anti-inflammatory or an immunosuppressant medication.

It is used in treatment of different conditions such as allergic disorders, skin conditions, ulcerative colitis, arthritis, lupus, psoriasis, or breathing disorders, Strides said.

The company has 126 cumulative abbreviated new drug application (ANDA) filings with USFDA of which 89 ANDAs have been approved and 37 are pending approval, it added.

Shares of Strides Pharma Science on Thursday closed 0.90 per cent lower at Rs 606.50 per scrip on the BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)